PCAS After changing its logo and launching a new website (www.pcas.com), the Extraordinary Shareholder's Meeting of the company Produits Chimiques et Auxiliaires de Synthèse has decided to change its corporate name to PCAS.
About PCAS (Euronext Paris: BCP, eligible for the PEA-PME plan)PCAS specialises in the development and production of complex molecules for Life Sciences and Innovative Technologies. With 7% of its turnover dedicated to R&D and a wide international presence, PCAS is the preferred industrial partner of market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments, and also includes two subsidiaries with very strong potential: Protéus in biotechnology and Enersens in high-performance insulation. With a particularly high standard of performance, PCAS achieved net sales of €179,1 million in 2015 and employs nearly 900 people in six countries.
For more information about PCAS: www.pcas.com
PCAS | NewCap |
Vincent Touraille / Eric Moissenot PCAS | Emmanuel Huynh NewCap Financial Communication & investors relations |
Tel. : +33 1 69 79 61 32 www.pcas.com | Tel. : +33 1 44 71 94 94 pcas@newcap.eu |
PCAS SA issued this content on 27 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 28 April 2016 00:38:18 UTC
Original Document: http://www.pcas.com/content/download/4294/70484/version/1/file/PCAS_-_Corporate_name_change_27042016.pdf
